
General Information
PEG L-APARAGIN 3750 IU/5 mL Injection is a pegylated form of L-asparaginase. It belongs to the antineoplastic/chemotherapy class and is used primarily in the treatment of acute lymphoblastic leukemia (ALL).
The medicine works by reducing the availability of asparagine, an amino acid that certain leukemia cells depend on for growth and survival.
2. Product Information
| Product Detail | Information |
|---|---|
| Product Name | PEG L-APARAGIN 3750 IU/5 mL Injection |
| Active Ingredient | Pegylated L-asparaginase / Pegaspargase |
| Strength | 3750 IU/5 mL |
| Dosage Form | Injection |
| Pack Form | 5 mL vial |
| Therapeutic Class | Antineoplastic / Chemotherapy |
| Primary Indication | Acute Lymphoblastic Leukemia (ALL) |
| Administration | IV or IM, as directed by the treating specialist |
| Prescription Status | Prescription medicine |
The 3750 IU/5 mL presentation is also listed in Indian procurement and pharmaceutical sources as pegylated L-asparaginase injection.
3. Uses of PEG L-APARAGIN 3750 IU/5 mL
PEG L-APARAGIN is primarily used:
- In acute lymphoblastic leukemia (ALL) treatment.
- As part of a combination chemotherapy regimen.
- In selected patients who require a pegylated asparaginase preparation.
- In certain treatment protocols where conventional asparaginase is unsuitable because of hypersensitivity, according to the treating specialist and applicable protocol.
The exact indication and chemotherapy combination depend on the patient's diagnosis and treatment protocol.
4. Benefits of This Medicine
The potential therapeutic benefits include:
- Helps deplete asparagine in the blood.
- Targets an important metabolic requirement of certain leukemia cells.
- Helps inhibit the growth and survival of susceptible leukemia cells.
- The PEGylated formulation provides prolonged activity, which can allow less frequent administration compared with some non-pegylated formulations.
It is important to understand that this medicine is not a standalone cure for leukemia. It is generally used as one component of a broader chemotherapy protocol.
5. Side Effects of PEG L-APARAGIN
Like other chemotherapy medicines, pegylated L-asparaginase can cause adverse effects. Important possible reactions include:
- Allergic or hypersensitivity reactions
- Pancreatitis
- Liver toxicity
- Blood-clotting problems
- Bleeding
- High blood glucose
- Nausea and vomiting
- Diarrhea
- Fever
- Fatigue
- Dizziness
- Abnormal liver-function tests
Serious complications such as severe allergic reactions, pancreatitis, thrombosis, hemorrhage and significant liver problems require prompt medical attention.
6. Common Side Effects
Some commonly reported or observed effects can include:
- Nausea
- Vomiting
- Diarrhea
- Fever
- Tiredness
- Dizziness
- Reduced appetite
- Changes in liver-function tests
- Changes in blood glucose
Not every patient experiences these effects, and their severity can vary.
Seek urgent medical attention for symptoms such as difficulty breathing, severe abdominal pain, unusual bleeding, sudden weakness/numbness, severe headache, swelling of a limb, yellowing of the skin/eyes, or other signs of a serious reaction.
7. How to Use
PEG L-APARAGIN 3750 IU/5 mL should not be self-administered.
- It must be administered by a qualified healthcare professional.
- The oncologist determines the appropriate dose and treatment schedule.
- Administration may be by intravenous or intramuscular route, depending on the prescribed product and treatment protocol.
- The patient should remain under appropriate medical observation during treatment because hypersensitivity and other serious reactions can occur.
- Do not change the dose or treatment schedule without the oncologist's instruction.
8. How This Medicine Works
PEG L-APARAGIN contains pegylated L-asparaginase (pegaspargase).
L-asparaginase breaks down asparagine in the bloodstream. Certain leukemia cells, including susceptible ALL cells, have limited ability to produce sufficient asparagine themselves and therefore depend more heavily on circulating asparagine.
By lowering circulating asparagine, pegylated L-asparaginase can deprive these cells of an important component required for protein synthesis and survival, thereby helping inhibit their growth and promote their death.
9. Safety Advice
Pregnancy: Inform the doctor if you are pregnant, planning pregnancy, or could be pregnant. Treatment should be considered carefully by the treating physician.
Breastfeeding: Breastfeeding is generally not recommended during treatment unless specifically advised otherwise by the treating physician.
Liver disease: Tell your doctor about any history of liver disease. Severe liver impairment can be an important safety concern.
Pancreatitis: Inform your doctor about previous or current pancreatitis. A history of serious pancreatitis associated with asparaginase treatment can be a contraindication.
Blood clots/bleeding: Inform your healthcare team about previous blood clots, bleeding disorders, or medications that affect blood clotting.
Diabetes/high blood sugar: Blood glucose may need monitoring during treatment.
Drug interactions: Tell the oncologist about all medicines, particularly anticoagulants, antiplatelet medicines, corticosteroids and other chemotherapy agents.
Storage: The product should generally be maintained under refrigerated conditions, commonly 2°C–8°C, according to the specific manufacturer's labeling. Do not freeze unless the product labeling specifically permits it.
10. Frequently Asked Questions (FAQs)
Q1. What is PEG L-APARAGIN 3750 IU/5 mL Injection used for?
It is primarily used as part of chemotherapy for acute lymphoblastic leukemia (ALL).
Q2. What is the active ingredient?
It contains pegylated L-asparaginase (pegaspargase).
Q3. Can PEG L-APARAGIN be self-injected?
No. It should be administered by an appropriately trained healthcare professional.
Q4. How does PEG L-APARAGIN work?
It breaks down circulating asparagine, reducing an important nutrient available to susceptible leukemia cells.
Q5. Does it have serious side effects?
Yes. Serious reactions can include hypersensitivity, pancreatitis, thrombosis, bleeding and liver toxicity. Medical monitoring is essential.
Q6. Does it need refrigeration?
Yes. The product should generally be stored at 2°C–8°C, following the manufacturer's specific storage instructions.
Q7. Can it be used during pregnancy?
Pregnancy should be discussed with the treating oncologist before treatment because potential risks must be carefully evaluated.
Q8. Is PEG L-APARAGIN a chemotherapy medicine?
Yes. It is an antineoplastic medicine used as part of chemotherapy regimens.
Q9. What should I do if I develop severe abdominal pain?
Contact the treating medical team immediately because severe abdominal pain can be a warning sign of pancreatitis.
Q10. Can other medicines be taken with it?
Some medicines can interact with asparaginase-based therapy. Always provide your oncologist with a complete list of medicines and supplements you are taking.
11. Substitutes / Alternatives
Possible brand alternatives containing pegylated L-asparaginase/pegaspargase may include products such as:
- Asviia 3750 IU Injection
- Admagin-P 3750 IU Injection
- Hamsyl Injection
- Peg-Lasgen 3750 IU Injection
- Peg L-Aspatero 3750 IU Injection
- Other locally approved pegaspargase/pegylated L-asparaginase products.
Important: A substitute should not be selected solely by strength or brand name. The oncologist must confirm that the active ingredient, formulation, dosing schedule, route, and treatment protocol are appropriate.
12. SEO / B2B Keywords
- PEG L-APARAGIN 3750 IU/5 mL Injection exporter
- PEG L-APARAGIN 3750 IU Injection supplier India
- Pegaspargase 3750 IU injection exporter
- Pegylated L-asparaginase injection supplier
- Pegylated L-asparaginase 3750 IU 5 mL
- PEG L-APARAGIN injection wholesale supplier
- PEG L-APARAGIN pharmaceutical exporter India
- PEG L-APARAGIN 3750 IU manufacturer supplier
- Pegaspargase injection exporter from India
- Acute lymphoblastic leukemia medicine supplier
- ALL chemotherapy injection supplier India
- Anticancer injection exporter from India
- Oncology medicine exporter Nagpur India
- Pegaspargase 3750 IU wholesale supplier
- PEG L-asparaginase injection for ALL
- Pegylated asparaginase injection supplier India
- Buy PEG L-APARAGIN 3750 IU injection
- PEG L-APARAGIN 5 mL vial supplier
- Pegaspargase medicine exporter to USA
- Pegaspargase medicine exporter to UK
- Pegaspargase medicine exporter to Australia
- Pegaspargase medicine exporter to Singapore
- Pegaspargase medicine exporter to Canada
- Pegaspargase medicine exporter to South Korea
- Pegaspargase medicine exporter to UAE
- PEG L-APARAGIN 3750 IU/5 mL Injection exporter from Nagpur, India – Phoenix Exim
Keywords







